ABSI earnings: real EPS beat/miss history, analyst consensus Buy, P/E -9.93. Updated 2026-07-23.
Absci (ABSI) Research Hub
Absci (ABSI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 8.21 USD (-5.09%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.93, market cap 1.40B. This hub links to the full technical, earnings and options research available for ABSI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.21 USD (-5.09%) |
| 52-week range | 6.69 USD – 12 USD |
| Trend regime | Range |
| 14-day RSI | 40.8 (Bearish) |
| Trailing P/E | -9.93 |
| Market cap | 1.40B |
| Dividend yield | 0.00% |
Available research for ABSI
Covered Call on ABSI: how it works, illustrative setup around the real 8.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABSI: how it works, illustrative setup around the real 8.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABSI: how it works, illustrative setup around the real 8.21 USD price, max profit/loss, breakeven and when to use it. Educational.
ABSI technical analysis: range, last 8.21 USD, RSI 40.8, 52w range 6.69 USD–12 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ABSI in?
Absci (ABSI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABSI in an uptrend or downtrend?
As of 2026-09-11, ABSI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABSI's trailing P/E ratio?
ABSI's trailing P/E is -9.93, with a market cap of 1.40B. See the earnings research page for full valuation detail.